We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Cenix, Metanomics Partner to Develop Metabolomic Biomarkers
News

Cenix, Metanomics Partner to Develop Metabolomic Biomarkers

Cenix, Metanomics Partner to Develop Metabolomic Biomarkers
News

Cenix, Metanomics Partner to Develop Metabolomic Biomarkers

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Cenix, Metanomics Partner to Develop Metabolomic Biomarkers "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

As the agreement’s first work assignment, Metanomics Health has commissioned Cenix to undertake a target validation project for an undisclosed disease indication. Under the jointly developed work plan, Cenix will leverage its longstanding industry-leading expertise in high content screening, utilizing the Definiens XD image analysis platform, for comprehensive functional characterization of target genes designated by Metanomics Health. 

“We foresee very strong synergies between our own capabilities and the exciting approach taken by Metanomics Health towards biomarker discovery and validation,” said Dr. Christophe Echeverri, CEO/CSO of Cenix. “We appreciate and value the trust of our colleagues at Metanomics Health and look forward to advancing their programs”. 

Financial terms were not disclosed. 


Advertisement